<DOC>
	<DOC>NCT00349986</DOC>
	<brief_summary>The rationale of the study is to determine: - the first dose and the titration of basal insulin - the exact daily time administration of basal insulin in poorly controlled type II diabetic patients.</brief_summary>
	<brief_title>LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 Diabetes Mellitus Insufficient combined oral antidiabetic treatment (biguanide + sulfonylurea) BMI &gt;25 kg/m2 , &lt;30 kg/m2 HbA1c value &gt;7.0%, &lt;9.0% within one month Type 1 Diabetes Mellitus Known malignancy Drug or alcohol abuse Severe liver disease Renal failure (se Creatinine &gt; 150 micro mol/l) The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>